4536 - 4 months ASCENDING TRIANGLE══════════════════════════════
Since 2014, my markets approach is to spot
trading opportunities based solely on the
development of
CLASSICAL CHART PATTERNS
🤝Let’s learn and grow together 🤝
══════════════════════════════
Hello Traders ✌
After a careful consideration I came to the conclusion that:
-
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.50 EUR
163.09 M EUR
1.85 B EUR
302.09 M
About SANTEN PHARMACEUTICAL CO
Sector
Industry
CEO
Takeshi Ito
Website
Headquarters
Osaka
Founded
2016
ISIN
JP3336000009
FIGI
BBG000C2JZX7
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SANTEN PHARMA. stocks are traded under the ticker SZD.
We've gathered analysts' opinions on SANTEN PHARMA. future price: according to them, SZD price has a max estimate of 15.42 EUR and a min estimate of 10.49 EUR. Watch SZD chart and read a more detailed SANTEN PHARMA. stock forecast: see what analysts think of SANTEN PHARMA. and suggest that you do with its stocks.
Yes, you can track SANTEN PHARMA. financials in yearly and quarterly reports right on TradingView.
SANTEN PHARMA. is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
SZD earnings for the last quarter are 0.16 EUR per share, whereas the estimation was 0.16 EUR resulting in a −3.00% surprise. The estimated earnings for the next quarter are 0.12 EUR per share. See more details about SANTEN PHARMA. earnings.
SANTEN PHARMA. revenue for the last quarter amounts to 469.18 M EUR, despite the estimated figure of 470.32 M EUR. In the next quarter, revenue is expected to reach 467.89 M EUR.
SZD net income for the last quarter is 53.41 M EUR, while the quarter before that showed 50.86 M EUR of net income which accounts for 5.02% change. Track more SANTEN PHARMA. financial stats to get the full picture.
As of Apr 28, 2025, the company has 3.74 K employees. See our rating of the largest employees — is SANTEN PHARMA. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANTEN PHARMA. EBITDA is 406.87 M EUR, and current EBITDA margin is 23.21%. See more stats in SANTEN PHARMA. financial statements.
Like other stocks, SZD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANTEN PHARMA. stock right from TradingView charts — choose your broker and connect to your account.